Lv5
1218 积分 2024-04-23 加入
Understanding and approaching excessive daytime sleepiness
1个月前
已完结
Efficacy and safety of cefepime-nacubactam and aztreonam-nacubactam compared with imipenem-cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial
1个月前
已完结
Efficacy and safety of cefepime-nacubactam and aztreonam-nacubactam compared with imipenem-cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial
1个月前
已完结
Physical Accessibility of Medicines in Countries Hosting Trials for FDA Approvals
1个月前
已完结
Obesity, Severe Obesity, and Abdominal Obesity in US Youth and Adults From 1999 to 2023
2个月前
已完结
Randomized, Double-Blind, Placebo-Controlled Phase II Trial of AYP-101 (Soybean Phosphatidylcholine) for Submental Fat Reduction in Asian Adults
4个月前
已完结
Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances
5个月前
已完结
The burden of non-infectious intraocular inflammatory eye diseases: a systematic literature review
7个月前
已完结
Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study
7个月前
已完结
Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study
9个月前
已完结
皖公网安备34019202002308
